OTCMKTS:TSOI Therapeutic Solutions International (TSOI) Stock Price, News & Analysis → This Weight Loss Company Can't Make Enough Product (From Behind the Markets) (Ad) Free TSOI Stock Alerts $0.0008 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$0.0008▼$0.000950-Day Range N/A52-Week Range$0.0004▼$0.0024Volume2.73 million shsAverage Volume22.01 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Therapeutic Solutions International alerts: Email Address Ad Weiss Ratings[Urgent] Your ESG score is hereDid you know you probably already have an ESG score? As we speak, the powers that be are building a full-scale social credit system … And soon, it could be used to control the way you live your life.Click here to watch it before it’s too late. About Therapeutic Solutions International Stock (OTCMKTS:TSOI)Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPSA, a blend of NanoStilbene and broccoli sprout extracts; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. In addition, it develops therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology. Therapeutic Solutions International, Inc. was founded in 2007 and is headquartered in Elk City, Idaho.Read More TSOI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TSOI Stock News HeadlinesMay 29, 2024 | finance.yahoo.comSeismic Therapeutic to Participate in Upcoming June Investor ConferencesMay 24, 2024 | markets.businessinsider.comBuy Rating Affirmed for Silence Therapeutics on Promising siRNA Therapeutic Developments and Market PotentialJune 18, 2024 | Behind the Markets (Ad)Bigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.May 22, 2024 | msn.com12 Gives Back: Greenlock Therapeutic Riding CenterMay 22, 2024 | finance.yahoo.comAmorChem’s RNA Zipcode Delivery Technology Investment Exits via New York-Based Kodikaz Therapeutic Solutions, Inc.May 16, 2024 | businesswire.comTherapeutic Solutions International Receives Notice of Allowance for Landmark Patent Covering Cellular Therapy of Lung DiseasesMay 15, 2024 | finance.yahoo.comRondo Therapeutics to Showcase Next-Generation CD28 Bispecific Platform at Upcoming Therapeutic Antibody ConferencesMay 13, 2024 | msn.comTherapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapyJune 18, 2024 | Behind the Markets (Ad)Bigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.May 9, 2024 | finance.yahoo.comImmunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the BoardApril 23, 2024 | finance.yahoo.comGlobal Desmoid Tumors Drug Pipeline Research Report 2024: Therapeutic Assessment by Product Type, Stage, Route of Administration, and Molecule TypeApril 19, 2024 | morningstar.comTherapeutic Solutions International IncApril 14, 2024 | finance.yahoo.comAion Therapeutic Responds to First-Ever U.S. Drinking Water Standard Making PFAS Removal a Top PriorityApril 8, 2024 | usnews.comTherapeutic Vaccine Prevents Pancreatic Cancer's Recurrence in 3-Year TrialApril 8, 2024 | finance.yahoo.comTherapeutic Solutions International, Inc. (TSOI)April 2, 2024 | finance.yahoo.comKelonia Therapeutics to Present Preclinical Data Highlighting Therapeutic Potential of in vivo CAR-T Cell Therapy in Multiple MyelomaApril 2, 2024 | finance.yahoo.comTherapeutic mRNA Patent Monitoring Service 2024: Track Competitors' IP Activities and their Future IntentionsMarch 18, 2024 | msn.comAveeno Therapeutic Shave Gel with Oat and Vitamin E to Help Prevent Razor Bumps, Now 24% OffMarch 11, 2024 | msn.comRising Stars Therapeutic Riding Center: Cowgirl Bunco night coming soonMarch 11, 2024 | finance.yahoo.comArthritic Therapeutic Market to Reach $ 136.1 billion, Globally, by 2032 at 5.5% CAGR: Allied Market ResearchMarch 4, 2024 | finance.yahoo.comTherapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 PatientsFebruary 29, 2024 | finance.yahoo.comTherapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell ProductFebruary 26, 2024 | finance.yahoo.comTherapeutic Solutions International Files Patent on "Facilitating Effects" of JadiCells on Gene Therapy Mediated Cell DifferentiationFebruary 26, 2024 | businesswire.comTherapeutic Solutions International Files Patent on “Facilitating Effects” of JadiCells on Gene Therapy Mediated Cell DifferentiationFebruary 23, 2024 | benzinga.comTherapeutic Solns Intl Stock (OTC:TSOI), Analyst Ratings, Price Targets, PredictionsFebruary 20, 2024 | finance.yahoo.comBetter Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver DiseaseFebruary 18, 2024 | msn.comPatient safety advocate 'horrified' at government's plans to drop Therapeutic Products ActSee More Headlines Receive TSOI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Therapeutic Solutions International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:TSOI CUSIP883378101 CIK1419051 Webtherapeuticsolutionsint.com Phone(760) 295-7208FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Timothy George Dixon (Age 66)Chairman, CEO, President & CFO Comp: $240kDr. Feng Lin M.D. (Age 53)Ph.D., Chief Scientific Officer Dr. James Drew Veltmeyer M.D. (Age 58)Chief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory Board Ms. Famela Ramos (Age 47)Vice President of Business Development Ms. Serena RobellaDirector of SalesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors TSOI Stock Analysis - Frequently Asked Questions How have TSOI shares performed in 2024? Therapeutic Solutions International's stock was trading at $0.0010 at the beginning of the year. Since then, TSOI shares have decreased by 20.0% and is now trading at $0.0008. View the best growth stocks for 2024 here. Are investors shorting Therapeutic Solutions International? Therapeutic Solutions International saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 218,700 shares, a decrease of 24.6% from the May 15th total of 290,200 shares. Based on an average trading volume of 38,818,200 shares, the days-to-cover ratio is presently 0.0 days. View Therapeutic Solutions International's Short Interest. What other stocks do shareholders of Therapeutic Solutions International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Therapeutic Solutions International investors own include Carnival Co. & (CCL), Korea Electric Power (KEP), Redwood Trust (RWT), Signet Jewelers (SIG), Goldman Sachs Physical Gold ETF (AAAU), Aurora Cannabis (ACB), AeroVironment (AVAV), Booking (BKNG), Chimera Investment (CIM) and Enterprise Products Partners (EPD). How do I buy shares of Therapeutic Solutions International? Shares of TSOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TSOI) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Therapeutic Solutions International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Therapeutic Solutions International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.